Track topics on Twitter Track topics that are important to you
Cytokinetics (NASDAQ:CYTK) has announced its financial results for Q2 2018. As quoted in the press release: Net loss for the second quarter was $27.5 million, or $0.51 per share, compared to a net loss for the second quarter of 2017 of $29.1 million, or $0.60 per share. Cash, cash equivalents and investments totaled $232.0 million … Continued
The post Cytokinetics Reports Second Quarter 2018 Financial Results appeared first on Investing News Network.
Original Article: Cytokinetics Reports Second Quarter 2018 Financial ResultsNEXT ARTICLE